University of Oklahoma   Report issue

Academic/Hospital Phase 1 Phase 2 Phase 3 Phase 4
Founded: Norman OK United States (1890)

Organization Overview

First Clinical Trial
1990
NCT00571727
First Marketed Drug
None
First NDA Approval
None
Last Known Activity
2022

Timeline

NOW
  • Now

Alternative names

Barbara Carlson | Children's Hospital of Oklahoma | Children's Hospital Oklahoma University Medical Center | Lead Investigator for Ovarian Cohort A | Mark L. Wolraich | Mark L. Wolraich, M.D. | Obstetrics and Gynecology | Oklahoma Cardiovascular Research | Oklahoma University Cancer Institute | Oklahoma University Children's Hospital | Oklahoma University Health Science Center | Oklahoma University Health Sciences Center | OTRC, OU Children's Hospital Dept. of Pediatrics, OU Cancer Center | OUHSC | OUHSC and VAMC | Peggy and Charles Stephenson Oklahoma Cancer Center | Peggy Charles Stephenson Cancer Center | Professor, University of Oklahoma Health Sciences Center | Stephenson Cancer Center | Stephenson Cancer Center, University of Oklahoma Health Sciences Center | The University of Oklahoma | The University of Oklahoma College of Pharmacy | The University of Oklahoma, Department of Pediatrics | The University of Oklahoma Health Sciences Center | Univeristy of Oklahoma | Univeristy of Oklahoma Health Sciences Center | University of Oklahoma | University of Oklahoma College of Medicine | University of Oklahoma Health Science Center | University of Oklahoma Health Science Center, Dept of Medicine/CardioVascular section | University of Oklahoma Health Sciences Center Dept of OB/GYN | University of Oklahoma Health Sciences Center, Oklahoma City, USA | University of Oklahoma HSC | University of Oklahoma HSC, Dept. of Urology | University of Oklahoma Medicine/Cardiovascular Section | University of Oklahoma, Oklahoma City, OK | University of Oklahoma-Tulsa | University of Oklohoma | VA Medical Center and University of Oklahoma